Global Stem Cells Group is pleased to announce the establishment of a cell therapy and regenerative medicine facility in Indonesia. Global Stem Cells Groupis pleased to announce the establishment of a cell therapy and regenerative medicine facility in Indonesia. The new facility emphasizes Global Stem Cell Groups objectives of bringing the advances and benefits of regenerative medicine to parts of the world where they are less well known.
MIAMI and PITTSBURGH, June 30, 2022 /PRNewswire/ -- iTolerance, Inc., an early-stageregenerative medicine company developing technology to enable tissue, organoid or cell therapy without the need for life-long immunosuppressionandLyGenesis, Inc., a clinical-stage biotechnology company developing cell therapies for large unmet needs, today announced that they have entered into a joint research collaboration to evaluate the potential of iTOL-201, the product candidate in development using iTolerance's SA FasL microgel immune tolerance platform (iTOL-100) combined with LyGenesis' liver cell therapy (LYG-LIV-100), to enable ectopic livers to be grown without the need or immune suppression.
Stem Cell and Gene Therapy Biological Testing market analysis report comprises of the right information at fingertips which is the key to making faster and more informed decisions. The report can provide accurate, in-depth information on latest market trends, future directions and unexplored avenues across industry verticals.
The global Mobile Cardiac Telemetry Systems Market research report gives a comprehensive analysis of market size, market trends, and market growth prospects.
Scientists, including several from NIEHS, gathered in Atlanta for ENDO2022, the first in-person annual meeting of the Endocrine Society in three years.
Data Bridge Market Research analyses that the Hematopoietic stem cell transplantation market was valued at USD 2,337.43 million in 2021 and is expected to reach USD 5,664.54 million by 2029, registering a CAGR of 11.70% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework
Amendment added to Pennsylvania budget bill would make Pitt, other universities stop fetal tissue research An amendment just added to the state budget bill would make the University of Pittsburgh promise that they would stop fetal tissue research.
Research into the retina and optic nerve using stem-cell models has unveiled specific genetic markers of glaucomathe worlds leading cause of permanent blindness possibly opening up new treatments for the condition. Glaucoma is a blanket term describing a group of eye conditions that do damage to the retinal ganglion cellsneurons near the inner eye that make up the optic nerve.
The biotechs all new neurorestorative approach aims to rebuild and replace lost brain cells in Alzheimers that underlies clinical symptoms.
Global 3D Bioprinting MarketIs Expected To Reach USD 2.84 Billion By 2027 At A CAGR Of 20.3 percent. Maximize Market Research has published a report on theGlobal 3D Bioprinting Marketthat provides a detailed analysis for the forecast period of 2022 to 2027. Global 3D Bioprinting MarketScope: The report provides comprehensive market insights for industry stakeholders, including an explanation of complicated market data in simple language, the industrys history and present situation, as well as expected market size and trends
Recent Comments